JPWO2020073088A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020073088A5 JPWO2020073088A5 JP2021520168A JP2021520168A JPWO2020073088A5 JP WO2020073088 A5 JPWO2020073088 A5 JP WO2020073088A5 JP 2021520168 A JP2021520168 A JP 2021520168A JP 2021520168 A JP2021520168 A JP 2021520168A JP WO2020073088 A5 JPWO2020073088 A5 JP WO2020073088A5
- Authority
- JP
- Japan
- Prior art keywords
- lactobacillus
- disease
- inflammation
- gastrointestinal
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000186660 Lactobacillus Species 0.000 claims description 40
- 229940039696 Lactobacillus Drugs 0.000 claims description 20
- 206010061218 Inflammation Diseases 0.000 claims description 19
- 230000004054 inflammatory process Effects 0.000 claims description 19
- 241000186610 Lactobacillus sp. Species 0.000 claims description 17
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 15
- 210000001035 Gastrointestinal Tract Anatomy 0.000 claims description 14
- 241000577554 Lactobacillus zeae Species 0.000 claims description 14
- 210000003491 Skin Anatomy 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 14
- 210000001635 Urinary Tract Anatomy 0.000 claims description 13
- 239000012228 culture supernatant Substances 0.000 claims description 13
- 210000001503 Joints Anatomy 0.000 claims description 12
- 201000010099 disease Diseases 0.000 claims description 12
- 241000191682 Lactobacillus rapi Species 0.000 claims description 11
- 241000790171 Lactobacillus diolivorans Species 0.000 claims description 10
- 210000000282 Nails Anatomy 0.000 claims description 10
- 239000002609 media Substances 0.000 claims description 10
- 206010003816 Autoimmune disease Diseases 0.000 claims description 9
- 201000009596 autoimmune hypersensitivity disease Diseases 0.000 claims description 9
- 230000002496 gastric Effects 0.000 claims description 9
- 200000000018 inflammatory disease Diseases 0.000 claims description 9
- 206010060945 Bacterial infection Diseases 0.000 claims description 8
- 244000052616 bacterial pathogens Species 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 201000004624 dermatitis Diseases 0.000 claims description 6
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 5
- 206010009900 Colitis ulcerative Diseases 0.000 claims description 5
- 206010028694 Nail disease Diseases 0.000 claims description 5
- 201000009910 diseases by infectious agent Diseases 0.000 claims description 5
- 201000006704 ulcerative colitis Diseases 0.000 claims description 5
- 208000004998 Abdominal Pain Diseases 0.000 claims description 4
- 206010012735 Diarrhoea Diseases 0.000 claims description 4
- 208000008665 Gastrointestinal Disease Diseases 0.000 claims description 4
- 206010064147 Gastrointestinal inflammation Diseases 0.000 claims description 4
- 201000008286 diarrhea Diseases 0.000 claims description 4
- 201000002146 gastrointestinal system disease Diseases 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- 206010000496 Acne Diseases 0.000 claims description 3
- 206010003246 Arthritis Diseases 0.000 claims description 3
- 206010009887 Colitis Diseases 0.000 claims description 3
- 208000005679 Eczema Diseases 0.000 claims description 3
- 210000000981 Epithelium Anatomy 0.000 claims description 3
- 206010021198 Ichthyosis Diseases 0.000 claims description 3
- 206010021197 Ichthyosis Diseases 0.000 claims description 3
- 206010021972 Inflammatory bowel disease Diseases 0.000 claims description 3
- 206010037596 Pyelonephritis Diseases 0.000 claims description 3
- 241001303601 Rosacea Species 0.000 claims description 3
- 208000006641 Skin Disease Diseases 0.000 claims description 3
- 206010040872 Skin infection Diseases 0.000 claims description 3
- 206010040882 Skin lesion Diseases 0.000 claims description 3
- 208000002474 Tinea Diseases 0.000 claims description 3
- 241000893966 Trichophyton verrucosum Species 0.000 claims description 3
- 208000000143 Urethritis Diseases 0.000 claims description 3
- 206010046577 Urinary tract infection Diseases 0.000 claims description 3
- 201000005661 acute cystitis Diseases 0.000 claims description 3
- 201000003146 cystitis Diseases 0.000 claims description 3
- 231100000406 dermatitis Toxicity 0.000 claims description 3
- 231100001003 eczema Toxicity 0.000 claims description 3
- 239000001963 growth media Substances 0.000 claims description 3
- 201000004681 psoriasis Diseases 0.000 claims description 3
- 201000004700 rosacea Diseases 0.000 claims description 3
- 231100000444 skin lesion Toxicity 0.000 claims description 3
- 206010000060 Abdominal distension Diseases 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims description 2
- 206010011401 Crohn's disease Diseases 0.000 claims description 2
- 208000002925 Dental Caries Diseases 0.000 claims description 2
- 241000588724 Escherichia coli Species 0.000 claims description 2
- 206010016952 Food poisoning Diseases 0.000 claims description 2
- 208000007882 Gastritis Diseases 0.000 claims description 2
- 208000005577 Gastroenteritis Diseases 0.000 claims description 2
- 208000007565 Gingivitis Diseases 0.000 claims description 2
- 208000002551 Irritable Bowel Syndrome Diseases 0.000 claims description 2
- 208000009883 Joint Disease Diseases 0.000 claims description 2
- 210000003750 Lower Gastrointestinal Tract Anatomy 0.000 claims description 2
- 208000007117 Oral Ulcer Diseases 0.000 claims description 2
- 206010039073 Rheumatoid arthritis Diseases 0.000 claims description 2
- 208000007107 Stomach Ulcer Diseases 0.000 claims description 2
- 230000001464 adherent Effects 0.000 claims description 2
- 230000001684 chronic Effects 0.000 claims description 2
- 210000002919 epithelial cells Anatomy 0.000 claims description 2
- 210000004877 mucosa Anatomy 0.000 claims description 2
- 201000008482 osteoarthritis Diseases 0.000 claims description 2
- 230000001717 pathogenic Effects 0.000 claims description 2
- 244000052769 pathogens Species 0.000 claims description 2
- 201000008838 periodontal disease Diseases 0.000 claims description 2
- 201000007100 pharyngitis Diseases 0.000 claims description 2
- 230000001737 promoting Effects 0.000 claims description 2
- 230000036269 ulceration Effects 0.000 claims description 2
- 230000029663 wound healing Effects 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims 3
- 206010056396 Asymptomatic bacteriuria Diseases 0.000 claims 2
- 206010018836 Haematochezia Diseases 0.000 claims 1
- 206010021425 Immune system disease Diseases 0.000 claims 1
- 230000002757 inflammatory Effects 0.000 claims 1
- 230000002522 swelling Effects 0.000 claims 1
- 230000002485 urinary Effects 0.000 claims 1
- 244000005700 microbiome Species 0.000 description 2
- 208000002399 Aphthous Stomatitis Diseases 0.000 description 1
- 210000004369 Blood Anatomy 0.000 description 1
- 210000003608 Feces Anatomy 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 208000006551 Parasitic Disease Diseases 0.000 description 1
- 206010047461 Viral infection Diseases 0.000 description 1
- 208000001756 Virus Disease Diseases 0.000 description 1
- 201000004538 bacteriuria Diseases 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000029578 entry into host Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000017613 viral reproduction Effects 0.000 description 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2018903823A AU2018903823A0 (en) | 2018-10-10 | Compositions and methods of treatment of conditions of the gastrointestinal tract | |
| AU2018903823 | 2018-10-10 | ||
| AU2018903822A AU2018903822A0 (en) | 2018-10-10 | Compositions and methods of treatment of inflammatory conditions and infections | |
| AU2018903822 | 2018-10-10 | ||
| AU2019901176A AU2019901176A0 (en) | 2019-04-05 | Compositions and methods of treatment of inflammatory conditions and associated infections | |
| AU2019901176 | 2019-04-05 | ||
| AU2019901175 | 2019-04-05 | ||
| AU2019901175A AU2019901175A0 (en) | 2019-04-05 | Compositions and methods of treatment of conditions of the gastrointestinal tract | |
| PCT/AU2019/051092 WO2020073088A1 (fr) | 2018-10-10 | 2019-10-10 | Procédés de traitement d'affections inflammatoires et d'infections associées |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022504792A JP2022504792A (ja) | 2022-01-13 |
| JPWO2020073088A5 true JPWO2020073088A5 (fr) | 2022-10-19 |
Family
ID=70163621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021520168A Pending JP2022504792A (ja) | 2018-10-10 | 2019-10-10 | 炎症性疾患及び関連する感染の治療方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210338749A1 (fr) |
| EP (1) | EP3863656A4 (fr) |
| JP (1) | JP2022504792A (fr) |
| CN (1) | CN114206362A (fr) |
| AU (1) | AU2019356524A1 (fr) |
| CA (1) | CA3124725A1 (fr) |
| SG (1) | SG11202103567RA (fr) |
| WO (1) | WO2020073088A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4255456A1 (fr) * | 2020-12-01 | 2023-10-11 | Servatus Ltd | Méthodes pour améliorer la qualité du sommeil |
| WO2022120421A1 (fr) * | 2020-12-09 | 2022-06-16 | Servatus Ltd | Polythérapie pour les troubles inflammatoires des articulations |
| EP4387640A1 (fr) * | 2021-08-19 | 2024-06-26 | Société des Produits Nestlé S.A. | Postbiotique |
| EP4387639A1 (fr) * | 2021-08-19 | 2024-06-26 | Société des Produits Nestlé S.A. | Postbiotique |
| US20230141346A1 (en) * | 2021-11-05 | 2023-05-11 | Trillium Medical Products, LLC | Infused undergarment |
| WO2023097375A1 (fr) * | 2021-12-02 | 2023-06-08 | Servatus Ltd | Méthodes de traitement de la constipation |
| CN115725469B (zh) * | 2022-11-28 | 2024-05-14 | 广西大学 | 一株副干酪乳杆菌及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1306716B1 (it) * | 1999-06-21 | 2001-10-02 | Mendes S U R L | Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori. |
| US20040208863A1 (en) * | 2003-01-30 | 2004-10-21 | James Versalovic | Anti-inflammatory activity from lactic acid bacteria |
| ITMI20032391A1 (it) * | 2003-12-05 | 2005-06-06 | Consiglio Nazionale Ricerche | Olive da mensa contenenti microrganismi probiotici. |
| WO2009005379A1 (fr) * | 2007-07-03 | 2009-01-08 | Danuta Kruszewska | Nouvelles applications médicales de l'alpha-cétoglutarate |
| JP4876262B2 (ja) * | 2008-10-24 | 2012-02-15 | 防衛省技術研究本部長 | 抗炎症効果を有する新規植物性乳酸菌株、該菌株を用いた炎症性腸疾患又は慢性下痢症に対する予防及び治療剤、抑制剤並びに添加剤 |
| US9138441B2 (en) * | 2009-12-31 | 2015-09-22 | Ira Milton Trachtman | Compositions and method for treatment and prophylaxis of inflammatory bowel disease |
| US9492487B2 (en) * | 2010-02-01 | 2016-11-15 | Matthew Ryan Garner | Microbial product containing multiple microorganisms |
| KR101918792B1 (ko) * | 2011-05-16 | 2018-11-14 | 오르가노발란스 메디컬 아게 | 박테리아성 감기에 대한 신규 락트산 박테리아 및 그를 함유하는 조성물 |
| BR112015026773A2 (pt) * | 2013-04-23 | 2017-07-25 | Terragen Holdings Ltd | cepas bacterianas que têm atividade antimicrobiana e composições de controle biológico que compreendem as mesmas |
| ITMI20130793A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti. |
| KR20150023132A (ko) * | 2013-08-23 | 2015-03-05 | (주) 아이투비 | 아토피 피부용 조성물 |
| CN104000184A (zh) * | 2013-12-09 | 2014-08-27 | 胡安然 | 一种调理萎缩性胃炎的膳食 |
| WO2016179639A1 (fr) * | 2015-05-13 | 2016-11-17 | Markson Ro | Compositions probiotiques et leurs utilisations |
| CN106860441B (zh) * | 2017-02-10 | 2019-12-31 | 中国医学科学院医药生物技术研究所 | 4-氧代-2-丁烯酰胺衍生物在制备抑菌剂中的应用 |
| KR101917497B1 (ko) * | 2017-02-18 | 2018-11-09 | 박병희 | 신규한 락토바실러스 부크네리 및 이의 용도 |
| TWI607758B (zh) * | 2017-03-07 | 2017-12-11 | 景岳生物科技股份有限公司 | 改善乾癬症狀的副乾酪乳桿菌菌株ｇｍｎｌ－６５３及其組合物 |
| AU2018251616A1 (en) * | 2017-04-11 | 2019-10-17 | Servatus Ltd | Methods for the treatment of inflammation and inflammatory conditions |
| WO2019178309A1 (fr) * | 2018-03-14 | 2019-09-19 | Sustainable Community Development, Llc | Composition probiotique et additif alimentaire |
-
2019
- 2019-10-10 US US17/284,207 patent/US20210338749A1/en active Pending
- 2019-10-10 CA CA3124725A patent/CA3124725A1/fr active Pending
- 2019-10-10 AU AU2019356524A patent/AU2019356524A1/en active Pending
- 2019-10-10 CN CN201980082026.6A patent/CN114206362A/zh active Pending
- 2019-10-10 EP EP19870476.9A patent/EP3863656A4/fr active Pending
- 2019-10-10 WO PCT/AU2019/051092 patent/WO2020073088A1/fr unknown
- 2019-10-10 JP JP2021520168A patent/JP2022504792A/ja active Pending
- 2019-10-10 SG SG11202103567RA patent/SG11202103567RA/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112534043B (zh) | 副干酪乳杆菌菌株及其用途 | |
| JP3944076B2 (ja) | 乳酸菌含有プロバイオティクス製品 | |
| JP3993168B2 (ja) | ラクトバシルス・ペントサス株を含む組成物およびそれらの使用 | |
| Meurman et al. | Recovery of Lactobacillus strain GG (ATCC 53103) from saliva of healthy volunteers after consumption of yoghurt prepared with the bacterium | |
| ES2269480T3 (es) | Uso de una cepa de lactobacillus que reduce los factores de riesgo asociados al sindrome metabolico. | |
| US20020022019A1 (en) | Method of reducing ecologically adverse changes of the gastro intestinal microbial flora in patients under treatment with medicaments | |
| US20030180260A1 (en) | Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor | |
| JP2012512171A (ja) | 改善された口腔健康のための組成物及び方法 | |
| EP1162987B1 (fr) | Composition pharmaceutique a usage medical et veterinaire utilisee pour regenerer la flore intestinale en cas de diarrhee ou de syndrome dyspeptique | |
| US20160279180A1 (en) | Probiotic Strain of Lactobacillus Reuteri Exhibiting Anti-Helicobacter Activity, a Probiotic or Biotherapeutic Product Comprising Said Strain, and the Use Thereof | |
| JP2022504792A (ja) | 炎症性疾患及び関連する感染の治療方法 | |
| US20180353555A1 (en) | Compositions and methods for reducing flatulence | |
| WO2020098988A1 (fr) | Souches , composition et procédé d'utilisation | |
| Vince | Metabolism of ammonia, urea, and amino acids, and their significance in liver disease | |
| JPWO2020073088A5 (fr) | ||
| US11344587B2 (en) | Method of improving urogenital health using probiotic bacteria | |
| CN113633666A (zh) | 一种用于口腔口臭和炎症治疗的益生菌微生态制剂及其制备方法和应用 | |
| Shukla et al. | Probiotic characterization of lactobacilli and yeast strains isolated from whey beverage and therapeutic potential of Lactobacillus yoghurt in murine giardiasis | |
| JP2003527432A (ja) | 腹膜炎の治療のための乳酸菌の使用 | |
| JP2015180689A (ja) | 睡眠中の鼾および呼吸努力関連覚醒のための薬および処置 | |
| Thompson | Metabolism of neutral steroids | |
| Stjernquist-Desatnik | Persistence of Lactobacillus plantarum DSM 9843 on human tonsillar surface after oral administration in fermented oatmeal gruel: A pilot study | |
| Aji et al. | The Probiotic Role of Lactic Acid Bacteria (LAB) in Helicobacter Pylori Gastritis | |
| Petrushanko et al. | Therapeutic potential of lactobacilli-based drug in the treatment of generalized periodontitis | |
| Nikolov | Probiotics and mucosal immune response |